Clinical Trial Update: Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol [NA]

View source ↗

Summary

Post-approval study update for the Magna Mitral Pericardial Bioprosthesis shows the study protocol is completed and results have been posted. The study concerns…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure
• Mitral Valve Regurgitation

Drugs mentioned

• Magna Mitral Pericardial Bioprosthesis

Snippet

Sponsor: Edwards Lifesciences | Conditions: Coronary Artery Disease, Mitral Valve Regurgitation | NA | Status: COMPLETED | Results posted: 2025-05-14